Shares of Relief Therapeutics (OTCMKTS: RLFTF) Explode Over 200% On News – Mike Swanson (08/03/2020)

This has been a wild summer for penny stock trading. Today the Nasdaq went up again this morning with more buying in shares of Apple (NASDAQ: AAPL), but small cap stock traders are in wonder of the action in Relief Therapeutics (OTCMKTS: RLFTF), because it is up 230% so far today. The coronavirus and need for vaccines and treatments and the opportunity in a company that can potentially deliver on this need is driving investment and speculation in stocks that are positioned to be a part of this big trend. Take a look at the chart of RLFTF yourself to see the action today.

What is driving the news is results from its coronavirus treatment drug NeuroX in a trial. The CEO Jonathan Javitt said this morning that “No other antiviral agent has demonstrated rapid recovery from viral infection and demonstrated laboratory inhibition of viral replication.”

“We are conducting placebo-controlled trials to see whether the observations made in the case-control and open-label studies will be confirmed for less ill patients with COVID-19-related respiratory failure. Our independent data monitoring committee will be conducting an interim analysis of this data later this month,” he added.

This has driven a lot of interest on Twitter from stock traders as you can see from these tweets.

I have no position in this stock. I would have bought if I had known this news and price rally was coming, but I had no way to know that. There are specific stock setups I do like to trade though. In July my top stock pick simply soared and I’m getting ready for a new one tomorrow.

To get this stock pick just join my stock trading email alert list for free by clicking here.

-Mike



Share This Post